Abstract
We report three cases of pathological gambling induced by Aripiprazole, in patients with schizophrenia or schizoaffective disorder. All three patients had no history of pathological gambling, and they started gambling after initiation of treatment with Aripiprazole. The fact that pathological behavior disappeared quickly as medication ends suggests that an elaborate behavioral manifestation could be related to dopaminergic tone in patients with schizophrenia. We recommend consideration with increased attention for the appearance of pathological gambling symptoms among patients on Aripiprazole.
Keywords: Pathological gambling, schizophrenia, schizoaffective disorder, dopamine agonist, behavioral addiction, dopamine D3 receptor, Aripiprazole, PG, DSM -IV, ICD, SOGS, MINI, Gender (M/F), Age, bipolar disorder., Hypersexuality, MCL, Amilsupride, Risperidone, Haldol, compulsive eating, stimulation, dopaminergic
Current Drug Safety
Title: Aripiprazole-Induced Pathological Gambling: A Report of 3 Cases
Volume: 6 Issue: 1
Author(s): Julien Cohen, David Magalon, Laurent Boyer, Nicolas Simon and Christophe Lancon
Affiliation:
Keywords: Pathological gambling, schizophrenia, schizoaffective disorder, dopamine agonist, behavioral addiction, dopamine D3 receptor, Aripiprazole, PG, DSM -IV, ICD, SOGS, MINI, Gender (M/F), Age, bipolar disorder., Hypersexuality, MCL, Amilsupride, Risperidone, Haldol, compulsive eating, stimulation, dopaminergic
Abstract: We report three cases of pathological gambling induced by Aripiprazole, in patients with schizophrenia or schizoaffective disorder. All three patients had no history of pathological gambling, and they started gambling after initiation of treatment with Aripiprazole. The fact that pathological behavior disappeared quickly as medication ends suggests that an elaborate behavioral manifestation could be related to dopaminergic tone in patients with schizophrenia. We recommend consideration with increased attention for the appearance of pathological gambling symptoms among patients on Aripiprazole.
Export Options
About this article
Cite this article as:
Cohen Julien, Magalon David, Boyer Laurent, Simon Nicolas and Lancon Christophe, Aripiprazole-Induced Pathological Gambling: A Report of 3 Cases, Current Drug Safety 2011; 6 (1) . https://dx.doi.org/10.2174/157488611794480016
DOI https://dx.doi.org/10.2174/157488611794480016 |
Print ISSN 1574-8863 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3911 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Using β-Amino Acids and β-Peptide Templates to Create Bioactive Ligands and Biomaterials
Current Pharmaceutical Design Effects of 8-Residue Beta Sheet Breaker Peptides on Aged Aβ40 – Induced Memory Impairment and Aβ40 Expression in Rat Brain and Serum Following Intraamygdaloid Injection
Current Alzheimer Research Antisense Treatment in Human Prostate Cancer and Melanoma
Current Cancer Drug Targets Natural Product Inhibitors of Acetylcholinesterase
Current Organic Chemistry Endothelial Function Assessment in Complicated Hypertension
Current Pharmaceutical Design Inhibition of Opioid Receptor Mediated G-Protein Activity After Chronic Administration of Kynurenic Acid and its Derivative without Direct Binding to Opioid Receptors
CNS & Neurological Disorders - Drug Targets Beta-Amyloid, Oxidative Stress and Down Syndrome
Current Alzheimer Research Effect of Coenzyme Q10 Supplementation on Urinary and Salivary Oxidative Stress Biomarkers in Bipolar Patients During the Depressive Episode
The Natural Products Journal Does Calprotectin Represent a Regulatory Factor in Host Defense or a Drug Target in Inflammatory Disease?
Endocrine, Metabolic & Immune Disorders - Drug Targets Imaging of Spinal Bone Tumors: Principles and Practice
Current Medical Imaging Elevation of E-Selectin Concentrations may Correlate with Potential Endothelial Dysfunction in Individuals with Hypopituitarism During Therapy with Growth Hormone
Current Neurovascular Research Regulation of HIF-1α at the Transcriptional Level
Current Pharmaceutical Design Cytokine Gene Polymorphism in Heart Transplantation: A Review
Current Genomics Non-coding RNAs: Cracking the Code for Clinical Disease
Current Neurovascular Research Patient Education and Telemedicine in COPD
Current Respiratory Medicine Reviews A Novel Tetradentate Ruthenium(II) Complex Containing Tris(2- pyridylmethyl)amine (tpa) as an Inhibitor of Beta-Amyloid Fibrillation
Current Alzheimer Research Sealing the Broken Barrier in IBD: Intestinal Permeability, Epithelial Cells and Junctions
Current Drug Targets Pyrimidine Derivatives as Potential Agents Acting on Central Nervous System
Central Nervous System Agents in Medicinal Chemistry Immune Cell Entry to Central Nervous System - Current Understanding and Prospective Therapeutic Targets
Endocrine, Metabolic & Immune Disorders - Drug Targets Effect of Systemic Inflammation on the Function of Insulin and Glucose Metabolism in Rheumatoid Arthritis
Current Diabetes Reviews